Random C-peptide in the classification of diabetes. (Q51550765)

6 April 2018

title

Random C-peptide in the classification of diabetes. (English)

1 reference

6 April 2018

author name string

Berger B

series ordinal

1

1 reference

6 April 2018

Stenström G

series ordinal

2

1 reference

6 April 2018

Sundkvist G

series ordinal

3

1 reference

6 April 2018

publication date

1 December 2000

1 reference

6 April 2018

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

6 April 2018

volume

60

1 reference

6 April 2018

issue

8

1 reference

6 April 2018

page(s)

687-693

1 reference

6 April 2018

Natural history of beta-cell dysfunction in NIDDM.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Classification of diabetes on the basis of etiologies versus degree of insulin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Diagnosing diabetes mellitus--do we need new criteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Assays for insulin, proinsulin(s) and C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Plasma and urinary C-peptide in the classification of adult diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Insulin Therapy in Relation to Circulating C-peptide Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Practical aspects in performing the glucagon test in the measurement of C-peptide secretion in diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

C-peptide uptake and excretion by the liver in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Basal C-peptide in the discrimination of type I from type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510050216411

10.1080/00365510050216411

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

11218151

1 reference

6 April 2018